ProMIS Neurosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Tables)

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2022

FAIR VALUE MEASUREMENTS

Summary of major categories of assets and liabilities measured at fair value on a recurring basis


		As of September 30, 2022
		Level 1			Level 2			Level 3			Total
Assets:
Short-term investments		$	30,539		$	—		$	—		$	30,539
Total assets measured at fair value		$	30,539		$	—		$	—		$	30,539
Liabilities:
Derivative liability		$	—		$	—		$	—		$	—
Warrant liability			—			—			1,553,186			1,553,186
Total liabilities measured at fair value		$	—		$	—		$	1,553,186		$	1,553,186


		As of December 31, 2021
		Level 1			Level 2			Level 3			Total
Assets:
Short-term investments		$	33,248		$	—		$	—		$	33,248
Total assets measured at fair value		$	33,248		$	—		$	—		$	33,248
Liabilities:
Derivative liability		$	—		$	—		$	5,379,878		$	5,379,878
Warrant liability			—			—			1,871,687			1,871,687
Total liabilities measured at fair value		$	—		$	—		$	7,251,565		$	7,251,565